Zevra Therapeutics (ZVRA) Exchange Rate Effect (2022 - 2026)
Zevra Therapeutics (ZVRA) reported Exchange Rate Effect of $233000.0 for Q1 2026, up 162.63% on a YoY basis from $88716.5 in Q1 2025, and up 172.36% quarter-over-quarter from -$322000.0 in Q4 2025.
Zevra Therapeutics (ZVRA) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Zevra Therapeutics has reported Exchange Rate Effect for 5 years, with the latest figure at $233000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 162.63% year-over-year to $233000.0; the trailing twelve-month figure through Mar 2026 stood at $633000.0 (up 398.43% YoY), and the FY2025 full-year result was $28000.0, down 93.83% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $233000.0, up from -$322000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $671000.0 in Q4 2024, with the low at -$491000.0 in Q3 2024.
- Historically, Exchange Rate Effect has averaged $64200.0 across 5 years, with a median of $64000.0 in 2025.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect sank 780.0% — and 2024, when it jumped 219.03%.
- Zevra Therapeutics' Exchange Rate Effect stood at $189000.0 in 2022, then jumped by 84.66% to $349000.0 in 2023, then jumped by 92.26% to $671000.0 in 2024, then plunged by 147.99% to -$322000.0 in 2025, then jumped by 172.36% to $233000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $233000.0 (Q1 2026), -$322000.0 (Q4 2025), and $64000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Zevra Therapeutics | 704.96 Mn | 504.34 Mn | 34.30 Mn | 233,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233,000.00 |
| Mar 31, 2026 | 233,000.00 |
| Dec 31, 2025 | -322,000.00 |
| Dec 31, 2025 | -322,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 658,000.00 |
| Mar 31, 2025 | -372,000.00 |
| Mar 31, 2025 | -372,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | -491,000.00 |
| Sep 30, 2024 | -491,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Dec 31, 2023 | 349,000.00 |